Mostrar el registro sencillo del ítem

dc.contributor.authorChapa, Christian
dc.date.accessioned2023-01-09T17:23:23Z
dc.date.available2023-01-09T17:23:23Z
dc.date.issued2022-08-01es_MX
dc.identifier.urihttp://cathi.uacj.mx/20.500.11961/24215
dc.description.abstractBackground: Drug delivery systems have been developed to treat diseases associated with the eye. However, one of the greatest challenges is to improve routes of administration, specifically the periocular and intravitreal, have the blood-retinal barrier as the greatest impediment. Lipid nanoparticles as a nucleic acid delivery system have been used as an alternative to treat ocular diseases, since they can cross the ocular barrier and efficiently transfecting nucleic acids to various cells of the eye. The size influences the transfection of genes, biological distribution, diffusion, and cellular uptake, so there are several factors that influence the characterization of the desired size for the nanoparticle. Several reported investigations vary in particle size and encapsulation efficiency, and a relationship between these variables has not been reported so far. Therefore, we propose the research question: What size of lipid nanoparticles targeting eye diseases has a higher encapsulation efficiency depending on the type of encapsulated nucleic acid? Methods: We used a search strategy to compare studies of nanomedicine systems aimed at eye diseases where the size of the nanoparticles and the efficiency of encapsulation of genetic material are reported based on the criteria of Preferred Reporting Items for Systematic Reviews (PRISMA ScR 2020 guidelines). Results: Out of the initial 5932, 169 studies met the inclusion criteria and were included to form the basis of the analysis. Nanoparticles reported are composed mainly of PEG-modified lipids, cholesterol and cationic lipids, that in combination with messenger or interference RNA, allows the formulation of a nanoparticle with an encapsulation efficiency greater than 95%. The diseases treated mainly focus on conditions related to the retina and cornea. Certain characteristics of nanoparticles increase encapsulation efficiency, such as the size of the nanoparticle and the charge of the outer layer of the nanoparticle, so it is essential to determine and further study the optimal characteristics to achieve an effective treatment. Although nucleic acid-loaded lipid nanoparticles are a promising treatment alternative, it still has some limitationses_MX
dc.description.urihttps://www.mrs-mexico.org.mx/imrc2022/system/app_abstract-registered.php?id_usr=01324es_MX
dc.language.isoenes_MX
dc.publisherSociedad Mexicana de Materialeses_MX
dc.relation.ispartofProducto de investigación IITes_MX
dc.relation.ispartofInstituto de Ingeniería y Tecnologíaes_MX
dc.subjectNanomedicinees_MX
dc.subjectLipid nanoparticleses_MX
dc.subjectEncapsulation Efficiencyes_MX
dc.subject.otherinfo:eu-repo/classification/cti/7es_MX
dc.titleTHE EFFICIENCY OF ENCAPSULATION OF NUCLEIC ACIDS IN LIPID NANOPARTICLES FOR THE TREATMENT OF EYE DISEASESes_MX
dc.typeMemoria en abstractes_MX
dcterms.thumbnailhttp://ri.uacj.mx/vufind/thumbnails/rupiiit.png
dcrupi.institutoInstituto de Ingeniería y Tecnologíaes_MX
dcrupi.cosechableSies_MX
dcrupi.subtipoInvestigaciónes_MX
dcrupi.alcanceInternacionales_MX
dcrupi.paisMéxicoes_MX
dc.contributor.coauthorOlivas Armendariz, Imelda
dc.contributor.alumno168456es_MX
dcrupi.tipoeventoCongresoes_MX
dcrupi.eventoXXX International Materials Research Congress and International Conference on Advanced Materialses_MX
dcrupi.estadoQuintana Rooes_MX
dc.contributor.coauthorexternoroacho Pérez, jorge
dcrupi.pronacesNingunoes_MX


Archivos en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem


Av. Plutarco Elías Calles #1210 • Fovissste Chamizal
Ciudad Juárez, Chihuahua, México • C.P. 32310 • Tel. (+52) 688 – 2100 al 09